Brought to you by 
BSC sells neurovascular unit to Stryker for $1.5bn
18 Feb 2011
Executive Summary
Gaining a new therapeutic area outside of its core orthopedic implants, Stryker Corp. has bought Boston Scientific Corp.'s neurovascular division for $1.4bn in cash up front plus $100mm in milestones. The acquired unit is the leading player in the global neurovascular market, which is worth $900mm.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com